KATHRYN E FALBERG Insider Trading $GYHT HALOZYME THERAPEUTICS, INC.
Get free email notifications about insider trading for KATHRYN E FALBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHRYN E FALBERG. KATHRYN E FALBERG is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Director in MEDIVATION, INC. ($MDVN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Director in aTYR PHARMA INC ($LIFE) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Axovant Sciences Ltd. ($AXON) and Director in Trade Desk, Inc. ($TTD) and Director in UroGen Pharma Ltd. ($URGN) and Director in Arcus Biosciences, Inc. ($RCUS) and Director in Nuvation Bio Inc. ($PANA).
KATHRYN E FALBERG in HALOZYME THERAPEUTICS, INC.
Trading Symbol: GYHTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KATHRYN E FALBERG: Director
Holdings: 358,253 shares
Latest Transaction: May 06 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KATHRYN E FALBERG in HALOZYME THERAPEUTICS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, RCUS, LIFE, BMRN, GYHT, HGSI, MDVN, NUVB, AXON, TTD, TCDA, URGN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 20,202 | 0 | 358,253 | 338.1 K to 358.3 K (+5.98 %) |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Option Exercise | M | 4.94 | 10,000 | 49,400 | 0 | |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Option Exercise | M | 10.37 | 10,000 | 103,700 | 0 | |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Buy | M | 4.94 | 10,000 | 49,400 | 338,051 | 328.1 K to 338.1 K (+3.05 %) |
Jan 14 2016 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Buy | M | 10.37 | 10,000 | 103,700 | 328,051 | 318.1 K to 328.1 K (+3.14 %) |
May 07 2015 | GYHT | HALOZYME THERAPEUT ... | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 13,175 | 0 | 318,051 | 304.9 K to 318.1 K (+4.32 %) |
Page: 1